Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News

11/29/2017 Rating of Russian Pharmaceutical Distributors (Q1 – Q3 2017)

The official start of labeling of pharmaceutical drugs is surely one of the most prominent events of 2017. It is both beneficial and risky for all market players. The benefits include more product distribution control opportunities for manufacturers. The risks involve the desire of the regulators to implement the system in a very short time, which can cause a wide variety of problems for the pharmaceutical wholesalers.

11/27/2017 Database Update: Pharmaceutical Drug Export from Russia (October 2017)

Between January and October 2017, Russia exported 16.7 bln RUB (customs paid) worth of pharmaceuticals (excluding EAEU countries), which is 2.2% lower than that of the same period of 2016. The exports in physical terms have risen by 5.4%, though, with 465.6 mln units of pharmaceuticals. The export line has been significantly expanded, with around 3,190 different trademarks.

11/24/2017 Dispatch Volumes of Pharmaceutical Drugs from Russian Manufacturers (October 2017)

Between January and October 2017, Russian manufacturers produced and dispatched 271 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 5.8% higher than that of the same period of 2016. In physical terms, the dynamics are 1.6%, with 3.45 bln units.

11/23/2017 Rating of Russian Retail Pharmacies (Q1 – Q3 2017)

The third quarter of 2017 turned out quite eventful for the Russian pharmaceutical retail industry, with various deals, including rather big ones, as well as a further discussion of certain regulatory issues, in particular, the possibility of selling pharmaceutical drugs in supermarkets.

11/17/2017 Database Update: Pharmaceutical Drug Import to Russia (October 2017)

Between January and October 2017, Russian imported 498.3 bln RUB worth of pharmaceutical drugs (free circulation prices, VAT included), which is in monetary terms 4.2% higher than that of the same period of 2016. Ready-made drugs account for most imports (420 bln RUB), with an 8.9% increase in monetary terms. The in-bulk import has fallen by as much as 15.4%, with 78.2 bln RUB.

11/16/2017 Database Update: Import of Veterinary Drugs, Feed Supplements, and Veterinary APIs to Russia (October 2017)

Between January and October 2017, Russia imported 18.5 bln RUB worth of veterinary drugs (free circulation prices), which is in monetary terms 6.2% higher than that of the same period of 2016. The import of feed supplements has risen by only 2.4%, with 25.5 bln RUB. The veterinary API import has the best dynamics, with a 14.2% increase and 1.4 bln RUB.

10/24/2017 Dispatch Volumes of Pharmaceutical Drugs from Russian Manufacturers (September 2017)

Between January and September 2017, Russian manufacturers produced and dispatched 241.3 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 7.2% higher than that of the same period of 2016. In physical terms, the dispatch volume amounted 3.08 bln units, which is only 2.1% higher than that of the same period of 2016.

10/13/2017 Database Update: Pharmaceutical Drug Import to Russia (September 2017)

During the first three quarters of 2017, Russia imported 372.2 bln RUB worth of ready-made pharmaceuticals (free circulation prices, VAT included), which is in monetary terms 9.5% higher than that of the same period of 2016. Then-bulk imports amounted to 70.1 bln RUB, which is 18% lower than that of the same period of 2016, despite the progress in August. Since January 2017, Russia has imported 442.3 bln RUB worth of pharmaceuticals, with the growth rates amounting to 3.9%, which barely cover the inflationary factor.

9/29/2017 Database Update: API Import to Russia (August 2017)

Between January and August 2017, Russia imported 48.9 bln RUB worth of APIs (free circulation prices, VAT included). Pharmacopoeial APIs account for most of the import (97.4%). The import has risen by 28% in monetary terms, with pharmacopoeial APIs contributing the most. The import of pharmacopoeial APIs has increased by 29%, while the import of technical APIs decreased by 2.4%.

9/20/2017 Dispatch Volumes of Pharmaceutical Drugs from Russian Manufacturers (August 2017)

Between January and August 2017, Russian manufacturers produced and dispatched 212.3 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 8.7% higher than that of the same period of 2016. In physical terms, the dispatch volume amounted to 2.73 bln units, which is 2.3% higher than that of the same period of 2016.